Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05813691
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-14
First Post:
2023-04-02
Brief Title:
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting a Spontaneous Opportunistic Screening Initiative
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study Overview
Official Title:
Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting a Spontaneous Opportunistic Screening Initiative
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ERADIcATE
Brief Summary:
The goal of this monocentric prospective observational study is to evaluate the prevalence of unknown hepatitis C virus chronic infection in general population born before january 1st 1968 in Italy
The main questions it aims to answer are
what is the prevalence of hepatits C virus infection in general population born before January 1st 1968 What rare the characteristics of these patients compared to the general population What is the prevalence of patients tested HCV positive who are referred to the Hepatology Outpatient Clinic for further evaluation What is the prevalence of patients with HCV infection detected during the study and treated with direct antiviral agents during follow up
Participants will be tested with a point of care screening test Meridian Bioscience able to detect anti-HCV antibodies to detect the presence of antibodies against HCV
The main questions it aims to answer are
what is the prevalence of hepatits C virus infection in general population born before January 1st 1968 What rare the characteristics of these patients compared to the general population What is the prevalence of patients tested HCV positive who are referred to the Hepatology Outpatient Clinic for further evaluation What is the prevalence of patients with HCV infection detected during the study and treated with direct antiviral agents during follow up
Participants will be tested with a point of care screening test Meridian Bioscience able to detect anti-HCV antibodies to detect the presence of antibodies against HCV
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None